Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
10/2005
10/19/2005EP1586319A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1586318A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585739A1 Substituted arylcyclopropylacetamides as glucokinase activators
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005CN1685014A Metal complexes as light-absorbing compounds in the information layer of optical data carriers
10/13/2005WO2005095368A1 Thiadiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005023183A3 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2561596A1 Thiadiazole-amine compounds for the treatment of neurodegenerative disorders
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005CN1681780A Biological low-molecular weight derivatives
10/12/2005CN1681768A Process for production of high-purity enamines
10/12/2005CN1680343A New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
10/12/2005CN1680342A Diazosulfide derivative and its synthesis and screening method for inducing anti-disease activity
10/11/2005US6953802 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
10/06/2005WO2005092873A2 Thiadiazoles for treatment of cancer or neurological disease
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092304A2 Antifungal agents
10/06/2005WO2005092099A1 Hiv integrase inhibitors
10/06/2005US20050222254 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222220 GSK-3 inhibitors
10/06/2005US20050222219 N-(1,3,4-thiadiazolyl)glycinamides, e.g., (S)-(6,8-Difluoro-1,2,3,4-tetrahydro-naphthalen-2-ylamino)-pentanoic acid [5-(1,1-dimethyl-but-3-enyl)-[1,3,4]thiadiazol-2-yl]-amide; treating diseases requiring inhibition of the production of A beta -peptide such as Alzheimer's disease
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222137 Combination of organic compounds
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005CA2557794A1 Opioid receptor antagonists
10/06/2005CA2557785A1 Hiv integrase inhibitors
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678311A Aryl carbonyl derivatives as therapeutic agents
10/05/2005CN1678298A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005CA2238275C Metalloproteinase inhibitors
09/2005
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005US20050215602 E. g., 2',3',4',5,5',6,7,8,9,10-decahydro-2-(2-pyrid-3-yl-ethanediylidene-),5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-1,2,5-thiadiazole-1',1'-dioxide; inhibitors of gamma-secretase to modulate the processing of amyloid precursor protein (APP)
09/29/2005US20050215578 Thiadiazole compounds and use thereof
09/29/2005CA2559919A1 Sulphonamide derivatives
09/28/2005EP1578885A2 Organic electroluminescent element
09/28/2005EP1578736A1 Mek inhibiting oxa- and thia-diazol-2-yl-phenylamine derivatives
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578359A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671675A 2, 1, 3-benzothiadiazoles for use as electronic active components
09/15/2005WO2005085220A1 Use of thiadiazole urea derivatives
09/15/2005WO2005054430A3 Hepatitis c virus inhibitors
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005DE102004009933A1 Use of 1,3,4-thiadiazole derivatives to prepare medicaments for treating diseases in which the inhibition, regulation or modulation of kinase signal transduction plays a role
09/15/2005CA2557303A1 Use of thiadiazole urea derivatives
09/14/2005EP1574505A1 1,2,4-thiadiazole compounds and use thereof
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/13/2005US6943159 amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor agonists or antagonists such as 3-Cyclohexyl-7-(1-hydroxyethyl)-1,2,3,4-tetrahydro-1,2,4-benzothiadiazine-1,1-dioxide, used for prophylaxis of nervous system disoders
09/13/2005CA2368650C Viral treatment
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/07/2005EP1569922A1 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same
09/07/2005EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217660C IL-8 receptor antagonists
09/01/2005WO2005080362A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
09/01/2005WO2005080360A1 Compounds
09/01/2005US20050192289 Novel cinnamic amides
09/01/2005US20050192280 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
09/01/2005US20050191570 Organophotoreceptor with charge transport compositions
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
09/01/2005CA2554686A1 Compounds
09/01/2005CA2552433A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
08/2005
08/31/2005EP1569040A2 Organophotoreceptor with charge transport compositions
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1661483A Organophotoreceptor with charge transport compositions
08/31/2005CN1660824A 2-substitution-5-(3, 4, 5-trialkoxy phenyl)-1, 3, 4-ramification of thiadiazoles and preparation method and biological activity
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/30/2005US6936700 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/30/2005US6936630 Sulfur compounds such as 1-(5-chloro-2-methyl-phenyl)-3-(3-methyl-isothiazol-5-yl)-thiourea, used for prophylaxis of cardiovascular disorders
08/30/2005US6936189 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
08/25/2005WO2005077925A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
08/25/2005WO2005077124A2 Compounds and compositions as lxr modulators
08/25/2005US20050187267 Nonsteroidal, nontoxic tissue selective modulators for side effect reduction; age-related and androgen-receptor related conditions such as sarcopenia; e.g. 4-(4-Hydroxy-1,1,3-trioxohexahydrothia-2,6a-diazapentalen-2-yl)-2-chloro-3-methylbenzonitrile
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 100